SC-560 |
Inhibitor of PTGS1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PTGS1 |
|
Inhibitor
300 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selective against COX-2 with IC50 6.3 μM and more than 40% of
remaining COX-2 activity at concent ...
Potency Cellular
In Vitro
PTGS1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1073/pnas.95.22.13313
In Vivo Validations
Rat
Dose: 10 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
5.4 ± 0.8 h
Systemic clearance:
1.15 ± 0.46 L/h/kg
Area Under the Curve::
9704 ± 4038 ng h/mL
Volume of Distribution at Steady-State:
9.1 ± 4.6 L/kg
Target engagement assay:
Oral dosing with either 10 or 30 mg/kg SC-560 1 hr before assay completely inhibited ionophore-stimulated TxB2 production in ex vivo assay
PMID Reference: 12935431
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
3.7 ± 1.6 (PEG) and 2.7 ± 1.7 (MC) h
Cmax:
218.5 ± 86.9 (PEG) and 119.8 ± 15.5 (MC) ng/mL
Tmax:
1.00 ± 1.8 (PEG) and 2.0 ± 0 (MC) h
Area Under the Curve::
1203.4 ± 130.3 (PEG) and 523 ± 208 (MC) ng*h/mL
PMID Reference: 12935431
Negative Control Compounds
Chemical Information
| Molecular Formula | C17H12ClF3N2O |
| SMILEs | COc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1 |
| InChI | InChI=1S/C17H12ClF3N2O/c1-24-14-8-6-13(7-9-14)23-15(10-16(22-23)17(19,20)21)11-2-4-12(18)5-3-11/h2-10H,1H3 |
| Molecular weight | 352.06 Da |
| AlogP | 5.220100000000003 |
| HBond acceptors | 3 |
| HBond donors | -- |
| Atoms | 36 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.